Skip to content

Epidaurus · Specialty

Going abroad for —

Therapeutic Interventions

Surgical procedures, non-surgical medical treatments, and pharmaceutical interventions across all major specialties

The country comparison

Which countries are best for therapeutic interventions

The destinations ranked high→low under this lens — each with the reasoning behind its score, the cited evidence one click down, and its full report. The verdict is free; the report is the depth.

19 / 19 Countries ranked

Researched and assessed by the Epidaurus editorial pipeline against our published scale. A country below the rule is not yet assessed enough — never ranked last.

  1. 1 Spain ES 4.6/5 Good Averages 4.6 across 20 of therapeutic interventions's 20 factors assessed so far. The full Spain profile
    The shape of Spain across Therapeutic Interventions 5 subcategories
    • Surgical Quality & Specialization 4.6 8/8
    • Non-Surgical Treatments 4.8 3/3
    • Cost Factors 4.0 3/3
    • Pharmaceutical Access 4.3 3/3
    • Infrastructure 4.8 3/3
  2. 2 Germany DE 4.3/5 Good Averages 4.3 across 20 of therapeutic interventions's 20 factors assessed so far. The full Germany profile
    The shape of Germany across Therapeutic Interventions 5 subcategories
    • Surgical Quality & Specialization 4.6 8/8
    • Non-Surgical Treatments 4.8 3/3
    • Cost Factors 3.5 3/3
    • Pharmaceutical Access 3.8 3/3
    • Infrastructure 4.0 3/3
  3. 3 Israel IL 4.3/5 Good Averages 4.3 across 20 of therapeutic interventions's 20 factors assessed so far. The full Israel profile
    The shape of Israel across Therapeutic Interventions 5 subcategories
    • Surgical Quality & Specialization 4.4 8/8
    • Non-Surgical Treatments 4.7 3/3
    • Cost Factors 3.8 3/3
    • Pharmaceutical Access 3.8 3/3
    • Infrastructure 4.7 3/3
  4. 4 Singapore SG 4.3/5 Good Averages 4.3 across 20 of therapeutic interventions's 20 factors assessed so far. The full Singapore profile
    The shape of Singapore across Therapeutic Interventions 5 subcategories
    • Surgical Quality & Specialization 4.7 8/8
    • Non-Surgical Treatments 4.8 3/3
    • Cost Factors 3.0 3/3
    • Pharmaceutical Access 3.3 3/3
    • Infrastructure 4.8 3/3
  5. 5 South Korea KR 4.3/5 Good Averages 4.3 across 20 of therapeutic interventions's 20 factors assessed so far. The full South Korea profile
    The shape of South Korea across Therapeutic Interventions 5 subcategories
    • Surgical Quality & Specialization 4.6 8/8
    • Non-Surgical Treatments 4.3 3/3
    • Cost Factors 4.3 3/3
    • Pharmaceutical Access 3.2 3/3
    • Infrastructure 4.8 3/3
  6. 6 Thailand TH 4.2/5 Good Averages 4.2 across 20 of therapeutic interventions's 20 factors assessed so far. The full Thailand profile
    The shape of Thailand across Therapeutic Interventions 5 subcategories
    • Surgical Quality & Specialization 4.3 8/8
    • Non-Surgical Treatments 4.0 3/3
    • Cost Factors 4.7 3/3
    • Pharmaceutical Access 3.7 3/3
    • Infrastructure 4.5 3/3
  7. 7 Turkey TR 4.2/5 Good Averages 4.2 across 20 of therapeutic interventions's 20 factors assessed so far. The full Turkey profile
    The shape of Turkey across Therapeutic Interventions 5 subcategories
    • Surgical Quality & Specialization 4.1 8/8
    • Non-Surgical Treatments 4.0 3/3
    • Cost Factors 4.8 3/3
    • Pharmaceutical Access 3.5 3/3
    • Infrastructure 4.7 3/3
  8. 8 India IN 4.1/5 Good Averages 4.1 across 20 of therapeutic interventions's 20 factors assessed so far. The full India profile
    The shape of India across Therapeutic Interventions 5 subcategories
    • Surgical Quality & Specialization 4.1 8/8
    • Non-Surgical Treatments 3.8 3/3
    • Cost Factors 4.8 3/3
    • Pharmaceutical Access 3.2 3/3
    • Infrastructure 4.3 3/3
  9. 9 Malaysia MY 4.1/5 Good Averages 4.1 across 20 of therapeutic interventions's 20 factors assessed so far. The full Malaysia profile
    The shape of Malaysia across Therapeutic Interventions 5 subcategories
    • Surgical Quality & Specialization 4.1 8/8
    • Non-Surgical Treatments 4.0 3/3
    • Cost Factors 4.5 3/3
    • Pharmaceutical Access 3.7 3/3
    • Infrastructure 4.5 3/3
  10. 10 United Arab Emirates AE 4.1/5 Good Averages 4.1 across 20 of therapeutic interventions's 20 factors assessed so far. The full United Arab Emirates profile
    The shape of United Arab Emirates across Therapeutic Interventions 5 subcategories
    • Surgical Quality & Specialization 4.4 8/8
    • Non-Surgical Treatments 4.2 3/3
    • Cost Factors 4.0 3/3
    • Pharmaceutical Access 2.5 3/3
    • Infrastructure 4.7 3/3
  11. 11 Brazil BR 4.0/5 Good Averages 4.0 across 20 of therapeutic interventions's 20 factors assessed so far. The full Brazil profile
    The shape of Brazil across Therapeutic Interventions 5 subcategories
    • Surgical Quality & Specialization 4.0 8/8
    • Non-Surgical Treatments 4.0 3/3
    • Cost Factors 4.0 3/3
    • Pharmaceutical Access 3.3 3/3
    • Infrastructure 4.5 3/3
  12. 12 Colombia CO 4.0/5 Good Averages 4.0 across 20 of therapeutic interventions's 20 factors assessed so far. The full Colombia profile
    The shape of Colombia across Therapeutic Interventions 5 subcategories
    • Surgical Quality & Specialization 4.1 8/8
    • Non-Surgical Treatments 3.5 3/3
    • Cost Factors 4.3 3/3
    • Pharmaceutical Access 4.0 3/3
    • Infrastructure 3.8 3/3
  13. 13 Japan JP 3.9/5 Moderate Averages 3.9 across 20 of therapeutic interventions's 20 factors assessed so far. The full Japan profile
    The shape of Japan across Therapeutic Interventions 5 subcategories
    • Surgical Quality & Specialization 4.2 8/8
    • Non-Surgical Treatments 4.3 3/3
    • Cost Factors 3.0 3/3
    • Pharmaceutical Access 3.0 3/3
    • Infrastructure 4.5 3/3
  14. 14 Hungary HU 3.8/5 Moderate Averages 3.8 across 20 of therapeutic interventions's 20 factors assessed so far. The full Hungary profile
    The shape of Hungary across Therapeutic Interventions 5 subcategories
    • Surgical Quality & Specialization 3.7 8/8
    • Non-Surgical Treatments 3.7 3/3
    • Cost Factors 4.5 3/3
    • Pharmaceutical Access 3.5 3/3
    • Infrastructure 3.5 3/3
  15. 15 Jordan JO 3.8/5 Moderate Averages 3.8 across 20 of therapeutic interventions's 20 factors assessed so far. The full Jordan profile
    The shape of Jordan across Therapeutic Interventions 5 subcategories
    • Surgical Quality & Specialization 3.9 8/8
    • Non-Surgical Treatments 4.0 3/3
    • Cost Factors 4.0 3/3
    • Pharmaceutical Access 3.0 3/3
    • Infrastructure 3.7 3/3
  16. 16 Mexico MX 3.8/5 Moderate Averages 3.8 across 20 of therapeutic interventions's 20 factors assessed so far. The full Mexico profile
    The shape of Mexico across Therapeutic Interventions 5 subcategories
    • Surgical Quality & Specialization 3.6 8/8
    • Non-Surgical Treatments 3.7 3/3
    • Cost Factors 4.7 3/3
    • Pharmaceutical Access 3.2 3/3
    • Infrastructure 3.8 3/3
  17. 17 Poland PL 3.8/5 Moderate Averages 3.8 across 20 of therapeutic interventions's 20 factors assessed so far. The full Poland profile
    The shape of Poland across Therapeutic Interventions 5 subcategories
    • Surgical Quality & Specialization 3.9 8/8
    • Non-Surgical Treatments 3.8 3/3
    • Cost Factors 4.2 3/3
    • Pharmaceutical Access 3.3 3/3
    • Infrastructure 3.7 3/3
  18. 18 United Kingdom GB 3.7/5 Moderate Averages 3.7 across 20 of therapeutic interventions's 20 factors assessed so far. The full United Kingdom profile
    The shape of United Kingdom across Therapeutic Interventions 5 subcategories
    • Surgical Quality & Specialization 4.3 8/8
    • Non-Surgical Treatments 4.0 3/3
    • Cost Factors 2.0 3/3
    • Pharmaceutical Access 3.3 3/3
    • Infrastructure 3.8 3/3
  19. 19 United States US 3.5/5 Moderate Averages 3.5 across 20 of therapeutic interventions's 20 factors assessed so far. The full United States profile
    The shape of United States across Therapeutic Interventions 5 subcategories
    • Surgical Quality & Specialization 4.5 8/8
    • Non-Surgical Treatments 4.7 3/3
    • Cost Factors 1.0 3/3
    • Pharmaceutical Access 2.3 3/3
    • Infrastructure 3.3 3/3

Where the choice turns

The factors that most separate the countries

A high average can hide the factor that actually decides your trip. These are the factors where the assessed countries sit furthest apart — open one to rank the whole field on it.

  1. Surgical Cost Savings Cost Factors 1.0 5.0 4.0 spread · 19 countries
  2. Cancer Treatment Cost Savings Cost Factors 1.0 5.0 4.0 spread · 19 countries
  3. Dental Cost Savings Cost Factors 1.0 5.0 4.0 spread · 19 countries
  4. Medication Cost Savings Pharmaceutical Access 1.0 4.5 3.5 spread · 19 countries
  5. Hospital Accreditation Infrastructure 2.0 5.0 3.0 spread · 19 countries

Drop into a single factor

The 20 factors behind this specialty

Want the comparison sharper than an average? Every factor opens onto its own worldwide country leaderboard. The figure beside each is how many of the 19 countries we have assessed on it.

Surgical Quality & Specialization 8 factors

Non-Surgical Treatments 3 factors

Cost Factors 3 factors

Pharmaceutical Access 3 factors

Infrastructure 3 factors

The reports

The full country reports under this lens

Each destination we have assessed has a full, cited report — the detailed analysis behind its score. The verdict is free; the report is the depth.

Clinics & providers

The clinics our research names

Named hospitals, clinics and centres cited across these findings — each carrying the specialties our reports record. Follow one to the reports behind it.

References

The sources behind these assessments

The distinct sources cited across these published reports — every finding carries its own citations; this is the union, each linking back to the reports that lean on it.

  1. Untitled source barosurgery.com/bariatric-fellowship/index.htm Cited in Bariatric Surgery Quality in India
  2. Untitled source clinirx.com/conducting-clinical-trials-in-india Cited in Clinical Trial Access in India
  3. Untitled source koreabizwire.com/average-doctors-salary-in-south-korea-tops-300-million-won-fueled-by-shortage/281249 Cited in Orthopedic Surgery Quality in South Korea
  4. Untitled source orthopaedicprinciples.com/wp-content/uploads/2011/10/newsletter_fellowships.pdf Cited in Orthopedic Surgery Quality in India
  5. Untitled source www.archiwum.mz.gov.pl/en/healthcare-system/health-personnel-and-training/recognition-of-professional-qualifications/recognition-of-doctors-and-dentists-specialist-title-obtained-in-or-previously-recognized-by-other-eu-member-state Cited in Specialist Credentials in Poland
  6. Untitled source www.bariatricmalaysia.com/prince-court-medical-centre Cited in Bariatric Surgery Quality in Malaysia
  7. Untitled source www.cancerindex.org/Thailand Cited in Chemotherapy & Immunotherapy Quality in Thailand
  8. Untitled source www.ctri.nic.in Cited in Clinical Trial Access in India
  9. Untitled source www.indianneurosurgery.com/microdiscectomy_surgery_india.html Cited in Neurosurgery Quality in India
  10. Untitled source www.innn.salud.gob.mx/interna/instituto/instituto.html Cited in Neurosurgery Quality in Mexico
  11. Untitled source www.jdchct.or.jp/en/data/slide/2023 Cited in Stem Cell Transplant Quality in Japan
  12. Untitled source www.jmatonline.com/view.php?id=2357 Cited in Bariatric Surgery Quality in Thailand
  13. Untitled source www.jointcommissioninternational.org/about-jci/jci-accredited-organizations/?c=Turkey Cited in Hospital Accreditation in Turkey
  14. Untitled source www.kmhglobal.com/national-cancer-center Cited in Oncologic Surgery Quality in South Korea
  15. Untitled source www.lawsturkey.com/law/2238-organ-transplantation-law Cited in Transplant Capabilities in Turkey
  16. Untitled source www.mdrindia.org Cited in Stem Cell Transplant Quality in India
  17. Untitled source www.mrmed.in/health-library/health-care/orphan-drugs-rare-diseases Cited in Medication Availability in India
  18. Untitled source www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832023000300363 Cited in Specialist Credentials in Mexico
  19. Untitled source www.scienceasia.org/2007.33(s1 Cited in Stem Cell Transplant Quality in Thailand
  20. Untitled source www.snuh.org/global/en/about/EN05006003.do Cited in Chemotherapy & Immunotherapy Quality in South Korea, Oncologic Surgery Quality in South Korea
  21. Untitled source www.snuh.org/global/en/find/findDeptView.do?dp_code=NS&hsp_cd=1 Cited in Neurosurgery Quality in South Korea
  22. Untitled source www.yakhak.org/journal/view.html?doi=10.17480/psk.2020.64.1.47 Cited in Medication Availability in South Korea
  23. Untitled source a1smiledesign.com/all-on-4 Cited in Dental Cost Savings in Mexico
  24. Untitled source aaoms.org Cited in Dental Surgery Quality in United States

Explore the source archive →

In plain language

Start exploring the knowledge base

The field's shorthand our reports use, sized by how often it comes up. Follow any term to its full entry and the reports that use it.

For readers weighing this decision

Ways to read the evidence

The verdict is always free. A membership opens the full analysis and every cited source — this specialty, the whole library, or everything for good.

  • One specialty · annual

    Therapeutic Interventions

    $49.00 / year

    $49.00/year

    Every report in this specialty — full analysis and every cited source — as each is published.

    Take this specialty

  • Full library · annual

    The whole library

    $199.00 / year

    $199.00/year

    The complete evidence behind every finding in every specialty, while your decision is live.

    Take the full library
  • Most readers

    Lifetime · one payment

    Everything, for good

    $499.00 once

    $499.00 (one-time)

    Every finding we publish today and hereafter — no renewal, no expiry. The tier we point most readers to.

    Take lifetime access

Prefer to pay per report? A single report is $29.00, yours to keep — browse the reports. The verdict is always free.

Where to go from here · Therapeutic Interventions

no scope is a dead end — step up to the specialty, drill into a factor, or pivot across to a country or a comparison